Targeting Toll-Like Receptor 4 (TLR4) and the NLRP3 Inflammasome: Novel and Emerging Therapeutic Targets for Hyperuricaemia Nephropathy. Biomol Biomed 2023, 688–697. https://doi.org/10.17305/bb.2023.9838.